Background Lupus nephritis (LN) is a severe consequence of systemic lupus erythematosus
(SLE) that affects approximately 40% of patients. Pathogenic immune complexes that are …

OBJECTIVE: To evaluate disease presentation, diagnosis, treatment, and clinical outcomes
in pregnancy-associated atypical hemolytic uremic syndrome (aHUS). DATA SOURCES: We …

Atypical hemolytic uremic syndrome (aHUS) is a rare cause of thrombotic microangiopathy
(TMA), characterized by microangiopathic hemolytic anemia, consumptive …

While there are increasing reports of acute kidney injury among hospitalized adults with
COVID-19, there is still limited information on renal complications associated with COVID-19 …

Thrombotic microangiopathy (TMA) is defined by specific clinical characteristics, including
microangiopathic hemolytic anemia, thrombocytopenia, and pathologic evidence of …

Hemolytic uremic syndrome (HUS) is a thrombotic microangiopathy (TMA) defined by the
clinical triad of thrombocytopenia, microangiopathic hemolytic anemia (MAHA) and renal …

Drug-induced thrombotic microangiopathy (DITMA) is a life-threatening complication that is
often under-recognized and under-reported (1). Despite recent systematic reviews …

The complement system is an important part of the innate immune system, providing a
strong defense against pathogens and removing apoptotic cells and immune complexes …

There is no approved therapy for coronavirus disease 2019 (COVID-19)[severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection], and the number of worldwide …

Aim: Atypical hemolytic uremic syndrome (aHUS), characterized by thrombotic
microangiopathy (TMA), is a genetic, life-threatening disease which needs many differential …